995 studies found for:    "Carcinoma, Hepatocellular"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Terminated SIR-Spheres® for the Treatment of Unresectable Hepatocellular Carcinoma
Conditions: Carcinoma, Hepatocellular;   Hepatoma
Intervention: Device: SIR-Spheres microspheres
2 Terminated Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)
Conditions: Hepatocellular Carcinoma Non-resectable;   Hepatocellular Carcinoma Recurrent;   Carcinoma, Hepatocellular;   Liver Diseases;   Neoplasms by Histologic Type;   Digestive System Neoplasms;   Carcinoma;   Liver Neoplasms;   Neoplasms;   Neoplasms by Site;   Digestive System Diseases;   Adenocarcinoma;   Neoplasms, Glandular and Epithelial
Interventions: Drug: ABT-869;   Drug: Sorafenib
3 Terminated
Has Results
Combination SBRT With TACE for Unresectable Hepatocellular Carcinoma
Conditions: Carcinoma, Hepatocellular;   Hepatobiliary Neoplasm;   Liver Carcinoma
Interventions: Procedure: TACE;   Procedure: SBRT
4 Completed Trial for Hepatocellular Carcinoma Adjuvant Treatment by Lipiocis
Conditions: Carcinoma, Hepatocellular;   Hepatitis, Viral, Human
Intervention: Drug: 131 I-lipiodol
5 Unknown  Proteomic Analysis of Human Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Intervention: Procedure: Operation
6 Recruiting SBRT for Hepatocellular Carcinoma Patients With Partial Response to TACE
Condition: Carcinoma, Hepatocellular
Intervention: Radiation: SBRT
7 Completed PI-88 in Hepatocellular Carcinoma After Hepatectomy
Condition: Carcinoma, Hepatocellular
Intervention: Drug: PI-88
8 Recruiting A Treatment of Unresectable Hepatocellular Carcinoma With TheraSphere®
Conditions: Liver Tumors;   Hepatocellular Carcinoma;   Hepatoma;   Neoplasms
Intervention: Device: TheraSphere®
9 Unknown  Trial of Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Interventions: Drug: epirubicin;   Drug: Cisplatin
10 Unknown  Treatment of Hepatocellular Carcinoma: Long-Acting Somatostatin Plus Percutaneous Ethanol Instillation (PEI) Versus Long-Acting Somatostatin Alone
Condition: Carcinoma, Hepatocellular
Intervention: Procedure: percutaneous ethanol instillation (PEI)
11 Unknown  Effect of Polymorphisms in the IL-1 Gene Complex on the Development of Chronic Hepatitis and Hepatocellular Carcinoma
Conditions: Hepatitis B;   Carcinoma, Hepatocellular;   Polymorphism, Genetic
Intervention:
12 Terminated Comparison Between Radiofrequency Versus Ethanol Injection for the Treatment of Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Intervention: Procedure: percutaneous ablation of hepatocellular carcinoma
13 Recruiting Transarterial Chemoembolization Versus Proton Beam Radiotherapy for the Treatment of Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Interventions: Procedure: Transarterial Chemoembolization;   Radiation: Proton Beam Radiotherapy
14 Completed A Phase II, Open-Label Trial Evaluating GV1001 in Advanced Hepatocellular Carcinoma.
Condition: Carcinoma, Hepatocellular
Intervention: Biological: GV1001
15 Enrolling by invitation Arsenic Trioxide TACE and Intravenous Administration in Unresectable Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Interventions: Device: Arsenic trioxide TACE;   Drug: Arsenic trioxide intravenous infusion;   Drug: lipiodol;   Drug: NaCl solution
16 Recruiting Phase I Study of Image-Guided Radiation Concurrent With Double-Agent Chemotherapy for Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Interventions: Radiation: IGRT;   Drug: Capecitabine;   Drug: Oxaliplatin
17 Recruiting Proton Beam Radiotherapy Plus Sorafenib Versus Sorafenib for Patients With Hepatocellular Carcinoma Exceeding San Francisco Criteria
Condition: Carcinoma, Hepatocellular
Interventions: Radiation: Proton Beam Radiotherapy;   Drug: Sorafenib
18 Terminated Phase III Study of PI-88 in Post-resection Hepatocellular Carcinoma
Conditions: Cancer;   Liver Cancer;   Primary Liver Cancer;   Hepatocellular Carcinoma;   Hepatoma
Interventions: Drug: PI-88;   Drug: placebo
19 Recruiting Efficacy, Safety, and Pharmacokinetic of MSC2156119J in Asian Subjects With Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Interventions: Drug: MSC2156119J;   Drug: Sorafenib
20 Recruiting Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 in Participants With Advanced Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Interventions: Drug: Part 1: JNJ-42756493;   Drug: Part 2: JNJ-42756493

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years